We use cookies to ensure that we give you the best experience on our website. By continuing to use our site, you are agreeing to our use of cookies. You can change your cookie settings at any time if you want. Find out more in our privacy and cookies policy.
Keep up with the latest news on Vertex's triple combination therapy, known as Trikafta in the US.
Kick-start your New Year with a super resolution! Sign up for an event or hold your own and help us fight for a life unlimited by cystic fibrosis (CF).
With four treks, three peaks and one ultra marathon in stunning locations across the UK you'll be spoilt for choice when picking your Great Strides™ challenge!
We're the largest charity funder of cystic fibrosis research in the UK. Explore some of our recent achievements, made possible by our supporters...
Cystic fibrosis is a genetic condition affecting more than 10,500 people in the UK. Find out why it's also a lot more than that.
Sign up to our e-newsletter to hear the latest news on what the Trust and its supporters are doing to fight for a life unlimited.
Join Team CF for this challenging walk up England's highest mountain.
NICE announce planned timeline for assessing Vertex’s triple combination therapy (known as Trikafta in the US) and the EMA allow more time in their process to assess who the license would cover.
We invest more money into cystic fibrosis research than any other UK organisation.
Find out more about our vision for a life unlimited by cystic fibrosis for everyone with the condition, and our strategy for getting there.
If you have a question, query, comment or suggestion, we'd love to hear from you.
Discover answers to frequently asked questions about cystic fibrosis.